|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Hawaii Biotech, Inc. Launches Vaccine Program To Protect Native Hawaiian Birds From West Nile; Likely West Nile Virus Spread Could Devastate Native Bird Population
10/19/2005 5:09:41 PM
HONOLULU--(BUSINESS WIRE)--June 2, 2005--Hawaii Biotech, Inc., a privately held biopharmaceutical company, announced today it has launched a vaccine program designed to protect Native Hawaiian bird species from the lethal West Nile virus. Over 300 bird species have been affected by West Nile virus since the mosquito-borne disease hit the U.S. in 1999. As some avian species are known to migrate from North America to Hawaii, a West Nile virus outbreak among endangered Hawaiian bird species is likely. Additionally, the virus could potentially be spread by infected mosquitoes or people traveling to the Hawaiian Islands. The spread of West Nile virus to Hawaii could decimate the Native Hawaiian bird population.
Anticipated collaborators include University of Hawaii, the National Wildlife Center, and the National Park Service. The program will first test the Hawaii Biotech vaccine's ability to protect U.S. mainland geese from infection by West Nile virus. If successful in these and other tests, the vaccine could be used to protect native Hawaiian birds, including the endangered state bird, the Hawaiian Nene goose.
|
|
|
|
|
|
|
|
|
|
|